Recombinant CD22 anticorps

N° du produit ABIN7795341

L’anticorps Human Monoclonal anti-CD22 a été validé pour FACS. Il convient pour détecter CD22 dans des échantillons de Humain.

Aperçu rapide pour Recombinant CD22 anticorps (ABIN7795341)

Antigène: CD22 (CD22 Molecule (CD22))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CD22 est non-conjugé

Application: Flow Cytometry (FACS)

Clone: NCI m971

Détail du produit anti-CD22 anticorps

Expression System: Mammalian cells

Fonction: Recombinant Anti-human Siglec-2/CD22 Monoclonal Antibody (Clone: NCI m971), Human IgG1 Fc Silent Kappa

Attributs du produit: The recombinant NCI m971 antibody binds to the human CD22 protein, a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice. In mice, it has been shown that CD22 blockade restores homeostatic microglial phagocytosis in aging brains.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

Isotype: Fc Silenced, IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur CD22

Antigène: CD22 (CD22 Molecule (CD22))

Autre désignation: Siglec-2/CD22